These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3534405)

  • 1. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. Criteria for the loss of BGA based on the staining pattern by the PAP method and its correlation with CEA and fibronectin].
    Nasu Y
    Nihon Hinyokika Gakkai Zasshi; 1986 Jun; 77(6):977-87. PubMed ID: 3534405
    [No Abstract]   [Full Text] [Related]  

  • 2. [Isoantigens ABH in bladder tumors as an indicator of malignant potential: a combined study with CEA, BMG, Leu-M1 and H-Ag].
    Saegusa M
    Hinyokika Kiyo; 1989 Aug; 35(8):1311-21. PubMed ID: 2683647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The study of the ABH isoantigen of bladder tumors].
    Fukatsu H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Takamura T; Yamada Y; Nishikawa E
    Hinyokika Kiyo; 1987 Jun; 33(6):857-63. PubMed ID: 3314420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen in cytological specimens of urothelial carcinoma.
    Holmberg V; Wahren B; Esposti PL
    Cytometry; 1984 Jul; 5(4):437-41. PubMed ID: 6380996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. III. Detection by PAP method and a classification of staining pattern].
    Nasu Y; Kumon H; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):739-43. PubMed ID: 6208400
    [No Abstract]   [Full Text] [Related]  

  • 6. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. IV. Correlation with Thomsen-Friedenreich antigen and CEA].
    Nasu Y; Kumon H; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1511-8. PubMed ID: 3807094
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of ABH antigens and CEA for the prognosis of urothelial tumors].
    Hofstädter F; Jakse G
    Wien Klin Wochenschr; 1982 Jul; 94(14):366-8. PubMed ID: 7147976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and ABO (H) blood group antigens on tissue sections of urinary bladder tumors].
    Fujioka T; Tanji S; Koike H; Kubo T; Ohhori T
    Hinyokika Kiyo; 1985 Oct; 31(10):1709-16. PubMed ID: 3911765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of transitional cell bladder carcinoma. With special reference to ABH blood group isoantigen expression and DNA analysis.
    Malmström PU
    Scand J Urol Nephrol Suppl; 1988; 112():1-55. PubMed ID: 3068792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. The staining pattern by PAP method and its correlation with prognosis].
    Saegusa M; Nasu Y; Kumon H; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1990 Feb; 81(2):196-203. PubMed ID: 1691319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEA and ABO(H) in upper urinary tract transitional tumors.
    Dalla Palma P; Parenti A; Poletti A
    Appl Pathol; 1984; 2(3):146-52. PubMed ID: 6399981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical localization of epithelial membrane antigen, carcinoembryonic antigen and secretory component in urinary bladder cancer].
    Takashi M; Murase T; Mitsuya H; Koshikawa T; Nagura H; Haimoto H
    Hinyokika Kiyo; 1986 Apr; 32(4):541-52. PubMed ID: 2426931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of ABH antigenicity of random mucosal biopsies and transitional cell carcinoma of the urinary bladder.
    Jakse G; Hofstädter F
    Eur Urol; 1983; 9(2):97-101. PubMed ID: 6852091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of CEA assay in tissue, serum and urine in patients with transitional cell carcinoma of the bladder.
    Alampi G; Ronchi E; Galassi A; Soli M; Botteghi B; Bercovich E
    Arch Anat Cytol Pathol; 1985; 33(4):193-6. PubMed ID: 3904640
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of blood group surface antigens of urinary bladder tumours using monoclonal antibodies with the avidin-biotin complex technique.
    Tan LB; Chiang C; Huang CH; Lin LM
    Int Urol Nephrol; 1992; 24(3):255-64. PubMed ID: 1399382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between tissue antigen analysis and plasma determinations for TPA and CEA in transitional cell carcinomas and in tumorfree urothelium of the urinary bladder.
    Vogel J; Oehr P; Maisey R; Adolphs HD
    Cancer Detect Prev; 1988; 11(3-6):389-96. PubMed ID: 2455597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urine examination for tumor cells using quantitative immunocytochemistry. Antibodies to a CEA-like antigen].
    Sautner D; Saeger W
    Fortschr Med; 1995 May; 113(14):207-9. PubMed ID: 7607589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and its correlation with grading and staging on tissue sections of urinary bladder carcinomas.
    Jautzke G; Altenaehr E
    Cancer; 1982 Nov; 50(10):2052-6. PubMed ID: 6751517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.